Accessory role of autologous T lymphocytes and adherent cells for the in vitro proliferation of T-cell colony-forming cells from patients with T-cell acute lymphoblastic leukemiaGEORGOULIAS, V; JASMIN, C.Leukemia research. 1985, Vol 9, Num 3, pp 357-367, issn 0145-2126Article

Interaction of captan with mammalian microtubulesSTOURNARAS, C; SARIDAKIS, I; FOSTINIS, Y et al.Cell biochemistry and function. 1991, Vol 9, Num 1, pp 23-28, issn 0263-6484, 6 p.Article

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancerLIANIDOU, E. S; MAVROUDIS, D; GEORGOULIAS, V et al.British journal of cancer. 2013, Vol 108, Num 12, pp 2426-2432, issn 0007-0920, 7 p.Article

Incidence of breast cancer on Crete, 1994-1995VLACHONIKOLIS, I. G; ALETRA, T. J; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 4, pp 574-577, issn 0959-8049Article

Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in GreeceMANIADAKIS, N; FRAGOULAKIS, V; PALLIS, A et al.Lung cancer. 2007, Vol 58, Num 2, pp 275-281, issn 0169-5002, 7 p.Article

Mortality from malignant neoplasms in Crete, 1992-1993VLACHONIKOLIS, I. G; PHILALITHIS, A. E; BRITTAN, Y et al.Journal of epidemiology and community health (1979). 1998, Vol 52, Num 2, pp 126-127, issn 0143-005XArticle

State of the art treatment for gastric cancer: future directionsCERVANTES, A; GEORGOULIAS, V; FALCONE, A et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 7, pp 40-47, issn 1359-6349, 8 p.Conference Paper

Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's diseaseSAMONIS, G; ANATOLIOTAKI, M; APOSTOLAKOU, H et al.Scandinavian journal of infectious diseases. 2001, Vol 33, Num 7, pp 553-555, issn 0036-5548Article

Interleukin 2 responsiveness of immature T-cell colony-forming cells (T-CFC) from patients with acute T-cell lymphoblastic leukemiasGEORGOULIAS, V; ALLOUCHE, M; SALVATORE, A et al.Cellular immunology (Print). 1987, Vol 105, Num 2, pp 317-331, issn 0008-8749Article

Synthetic peptides from the region 30-54 of the interleukin-2 receptor β-chain (IL-2Rβ) affect IL-2 binding to human T-cellsDRAKOPOULOU, E; SOTIROPOULOU, G; TSILIVAKOS, V et al.Collection of Czechoslovak chemical communications. 1994, Vol 59, Num 4, pp 943-950, issn 0010-0765Article

Spermicidal and antiviral properties of cholic acid : contraceptive efficacy of a new vaginal sponge (Protectaid®) containing sodium cholatePSYCHOYOS, A; CREATSAS, G; HASSAN, E et al.Human reproduction (Oxford. Print). 1993, Vol 8, Num 6, pp 866-869, issn 0268-1161Article

Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancerGEORGOULIAS, V; APOSTOLAKI, S; MAVROUDIS, D et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 6, pp 1217-1225, issn 0344-5704, 9 p.Article

A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancerAGELAKI, S; KONTOPODIS, E; KOTSAKIS, A et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 1, pp 45-51, issn 0344-5704, 7 p.Article

A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancerKARACHALIOU, N; KOUROUSSIS, Ch; PAPAKOTOULAS, P et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 5, pp 1345-1352, issn 0344-5704, 8 p.Article

A multicenter randomized phase III trial of vinorelbine/ gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancerPALLIS, A. G; BOUKOVINAS, I; ARDAVANIS, A et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1164-1169, issn 0923-7534, 6 p.Article

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II studyGEORGOULIAS, V; BOZIONELOU, V; AGELAKI, S et al.Annals of oncology. 2012, Vol 23, Num 7, pp 1744-1749, issn 0923-7534, 6 p.Article

Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss and Clinical Outcome in Metastatic Non-Small Cell Lung Cancer PatientsVLACHOSTERGIOS, P. J; GIOULBASANIS, I; KAMPOSIORAS, K et al.Oncology. 2011, Vol 81, Num 2, pp 113-118, issn 0030-2414, 6 p.Article

Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas : A multicenter phase II studyBOUKOVINAS, I; SOUGLAKOS, J; KALBAKIS, K et al.Lung cancer. 2009, Vol 63, Num 1, pp 77-82, issn 0169-5002, 6 p.Article

Ribonucleotide reductase subunits M 1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabineSOUGLAKOS, J; BOUKOVINAS, I; RESELL, R et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1710-1715, issn 0007-0920, 6 p.Article

A phase I study of the optimized cryptic peptide TERT_572Y in patients with advanced malignanciesMAVROUDIS, D; BOLONAKIS, I; MICONNET, I et al.Oncology. 2006, Vol 70, Num 4, pp 306-314, issn 0030-2414, 9 p.Article

A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumorsKOTSAKIS, A; KOUROUSSIS, Ch; MAVROUDIS, D et al.Oncology. 2006, Vol 71, Num 3-4, pp 190-196, issn 0030-2414, 7 p.Article

A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMAVROUDIS, D; PAPPAS, P; SAMONIS, G et al.Annals of oncology. 2003, Vol 14, Num 2, pp 304-312, issn 0923-7534, 9 p.Article

Assessment of vascular maturation using a new basement membrane epitope, LH 39. A new prognostic indicator in human neoplasia?KAKOLYRIS, S; AMARANTIDIS, K; KOUGIOUMTZIDOU, O et al.Recent research developments in cancer : Vol. 5 (2003). Recent research developments in cancer. 2003, pp 175-184, isbn 81-7895-099-5, 10 p.Book Chapter

Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: A multicenter phase II studyVAMVAKAS, L; KAKOLYRIS, S; GEORGOULIAS, V et al.American journal of clinical oncology. 2002, Vol 25, Num 1, pp 65-70, issn 0277-3732Article

Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer : A phase II studyKOUROUSSIS, Ch; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 61, Num 1, pp 36-41, issn 0030-2414Article